Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions.

Lester CA, Flynn AJ, Marshall VD, et al. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions. J Am Med Inform Assoc. 2022;29(9):1471-1479. doi:10.1093/jamia/ocac096.

Save
Print
August 31, 2022
Lester CA, Flynn AJ, Marshall VD, et al. J Am Med Inform Assoc. 2022;29(9):1471-1479.
View more articles from the same authors.

Although e-prescribing has improved the safety of medication ordering, preventable errors persist. This study analyzed product descriptions (ingredient, strength, dose form) of more than 10 million e-prescriptions. Results show a wide variety in the way drug product descriptions are entered into e-prescription programs (e.g., 707 variants for “oral tablet” such as tablet, tab, po tab). Poor standardization of terminology in e-prescription programs can lead to incorrect medication order and patient confusion.

Save
Print
Cite
Citation

Lester CA, Flynn AJ, Marshall VD, et al. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions. J Am Med Inform Assoc. 2022;29(9):1471-1479. doi:10.1093/jamia/ocac096.